graft versus host disease prophylaxis/therapy

BIOLOGICAL7 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Fred Hutchinson Cancer Center, Memorial Sloan Kettering Cancer Center, Case Comprehensive Cancer Center, University of Nebraska

Conditions

Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaAtypical Chronic Myeloid Leukemia, BCR-ABL1 Negative

Phase 1

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

CompletedNCT00361049

Case Comprehensive Cancer CenterCancer

Start: 2004-09-30End: 2010-11-30Updated: 2010-11-05

Phase 2

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

CompletedNCT00118352

Fred Hutchinson Cancer CenterAcute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission +61

Start: 2005-03-31End: 2015-05-26Updated: 2017-05-30

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

CompletedNCT00357396

Memorial Sloan Kettering Cancer CenterSarcoma

Start: 2005-06-30End: 2009-10-31Updated: 2015-11-25

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

TerminatedNCT01044745

University of NebraskaAccelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission +108

Start: 2009-12-10End: 2017-10-10Updated: 2023-09-06

Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease

CompletedNCT01616056

Fred Hutchinson Cancer CenterGraft Versus Host Disease, Ophthalmologic Complications

Start: 2012-06-30End: 2014-12-31Updated: 2017-07-17

Phase 3

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

CompletedNCT00265837

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsGraft Versus Host Disease, Leukemia, Lymphoma +3

Start: 2002-12-31End: 2007-08-31Updated: 2014-04-17

Unknown Phase

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

CompletedNCT00003538

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCancer

Start: 1997-03-31End: 2004-05-31Updated: 2014-05-02

Related Papers

Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation2015-07-1748 citations

A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation2015-01-22